Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:RDNTNASDAQ:SHCNYSE:TDOCNASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeRDNTRadNet$51.03+1.5%$51.44$45.00▼$93.65$3.78B1.59661,456 shs461,071 shsSHCSotera Health$11.26+1.0%$11.51$9.53▼$17.08$3.20B1.881.20 million shs832,394 shsTDOCTeladoc Health$7.16-0.6%$8.38$6.35▼$15.21$1.28B1.736.19 million shs4.43 million shsWGSGeneDx$112.49+1.3%$95.80$10.70▼$116.24$3.16B1.93699,256 shs1.38 million shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceRDNTRadNet+1.53%+7.75%+3.22%-22.61%+5.43%SHCSotera Health+0.99%+9.11%-4.33%-18.11%-1.23%TDOCTeladoc Health-0.42%+9.82%-11.77%-32.10%-44.97%WGSGeneDx+1.33%+23.56%+22.01%+41.96%+915.25%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationRDNTRadNet4.0092 of 5 stars3.71.00.04.63.52.50.0SHCSotera Health2.3877 of 5 stars3.30.00.00.02.63.31.3TDOCTeladoc Health3.477 of 5 stars4.24.00.00.01.12.51.3WGSGeneDx2.2223 of 5 stars1.32.00.00.04.14.21.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceRDNTRadNet 3.40Buy$69.7536.68% UpsideSHCSotera Health 2.60Moderate Buy$15.2034.99% UpsideTDOCTeladoc Health 2.39Hold$10.4646.03% UpsideWGSGeneDx 2.50Moderate Buy$72.33-35.70% DownsideCurrent Analyst Ratings BreakdownLatest TDOC, RDNT, SHC, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/25/2025TDOCTeladoc HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$11.00 ➝ $8.754/23/2025SHCSotera HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.004/21/2025TDOCTeladoc HealthJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $8.004/11/2025RDNTRadNetTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$88.00 ➝ $74.004/11/2025TDOCTeladoc HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$9.50 ➝ $8.004/10/2025SHCSotera HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$16.00 ➝ $12.003/24/2025RDNTRadNetBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$74.00 ➝ $60.003/5/2025RDNTRadNetRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOutperform ➝ Strong-Buy$85.00 ➝ $65.003/3/2025TDOCTeladoc HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $13.002/28/2025SHCSotera HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$17.00 ➝ $16.002/27/2025TDOCTeladoc HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$13.00 ➝ $12.00(Data available from 4/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookRDNTRadNet$1.83B2.07$2.71 per share18.81$11.79 per share4.33SHCSotera Health$1.10B2.90$1.10 per share10.27$1.57 per share7.17TDOCTeladoc Health$2.57B0.49$0.46 per share15.64$14.05 per share0.51WGSGeneDx$305.45M10.34N/AN/A$8.78 per share12.81Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateRDNTRadNet$3.04M$0.03N/A96.28N/A-0.25%4.29%1.45%5/6/2025 (Estimated)SHCSotera Health$51.38M$0.1545.0416.09N/A6.31%42.27%6.02%5/1/2025 (Estimated)TDOCTeladoc Health-$220.37M-$5.88N/AN/AN/A-37.91%-10.06%-4.86%4/30/2025 (Estimated)WGSGeneDx-$175.77M-$1.96N/A53.82N/A-17.12%3.33%1.69%4/30/2025 (Estimated)Latest TDOC, RDNT, SHC, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025RDNTRadNet-$0.16N/AN/AN/A$442.98 millionN/A5/1/2025Q1 2025SHCSotera Health$0.12N/AN/AN/A$245.56 millionN/A4/30/2025Q1 2025TDOCTeladoc Health-$0.32N/AN/AN/A$619.38 millionN/A4/30/2025Q1 2025WGSGeneDx$0.11N/AN/AN/A$79.90 millionN/A2/27/2025Q4 2024RDNTRadNet$0.21$0.22+$0.01$0.07$459.42 million$477.10 million2/26/2025Q4 2024TDOCTeladoc Health-$0.21-$0.28-$0.07-$0.28$639.44 million$640.49 million2/18/2025Q4 2024WGSGeneDx$0.04$0.70+$0.66$0.23$82.24 million$95.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthRDNTRadNetN/AN/AN/AN/AN/ASHCSotera HealthN/AN/AN/AN/AN/ATDOCTeladoc HealthN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioRDNTRadNet0.892.162.16SHCSotera Health4.912.882.61TDOCTeladoc Health0.661.731.69WGSGeneDx0.252.402.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipRDNTRadNet77.90%SHCSotera Health91.03%TDOCTeladoc Health76.82%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipRDNTRadNet5.12%SHCSotera Health55.12%TDOCTeladoc Health0.58%WGSGeneDx27.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableRDNTRadNet8,97074.04 million70.24 millionOptionableSHCSotera Health3,000283.86 million127.12 millionOptionableTDOCTeladoc Health5,100175.28 million170.53 millionOptionableWGSGeneDx1,20028.07 million19.97 millionOptionableTDOC, RDNT, SHC, and WGS HeadlinesRecent News About These Companies127,567 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Tri Locum Partners LPApril 29 at 6:51 AM | marketbeat.comLegal & General Group Plc Purchases 2,638 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)April 29 at 3:42 AM | marketbeat.comGeneDx: Strengthening Leadership In Genomic DiagnosticsApril 28 at 12:02 PM | seekingalpha.com630,473 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Lord Abbett & CO. LLCApril 28 at 5:56 AM | marketbeat.comBarclays PLC Has $6.18 Million Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)April 28 at 3:49 AM | marketbeat.comGeneDx Holdings Reaches Analyst Target PriceApril 26 at 6:29 PM | nasdaq.comScience & Technology Partners L.P. Makes New Investment in GeneDx Holdings Corp. (NASDAQ:WGS)April 26 at 7:17 AM | marketbeat.comRiverPark Advisors LLC Invests $233,000 in GeneDx Holdings Corp. (NASDAQ:WGS)April 26 at 6:43 AM | marketbeat.comGeneDx (WGS) Projected to Post Quarterly Earnings on WednesdayApril 25, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Up 7.1% - Still a Buy?April 24, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Acquired by Canada Pension Plan Investment BoardApril 24, 2025 | marketbeat.comGeneDx Holdings Corp. (WGS): Among the Best Multibagger Stocks to Buy According to BillionairesApril 24, 2025 | msn.comRaymond James Financial Inc. Makes New Investment in GeneDx Holdings Corp. (NASDAQ:WGS)April 22, 2025 | marketbeat.comWill Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results?April 21, 2025 | zacks.comAlpha DNA Investment Management LLC Sells 4,998 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)April 21, 2025 | marketbeat.comInvesco Ltd. Grows Stake in GeneDx Holdings Corp. (NASDAQ:WGS)April 21, 2025 | marketbeat.comAlliancebernstein L.P. Buys 5,900 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)April 21, 2025 | marketbeat.comGeode Capital Management LLC Buys 4,719 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)April 20, 2025 | marketbeat.comGeneDx Holdings Corp. (WGS) Rose on Robust Customer DemandApril 18, 2025 | finance.yahoo.comEAM Investors LLC Acquires 18,446 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)April 18, 2025 | marketbeat.comCraig-Hallum Sticks to Their Buy Rating for GeneDx Holdings (WGS)April 17, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTDOC, RDNT, SHC, and WGS Company DescriptionsRadNet NASDAQ:RDNT$51.03 +0.77 (+1.53%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$50.96 -0.08 (-0.15%) As of 09:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Sotera Health NASDAQ:SHC$11.26 +0.11 (+0.99%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$11.38 +0.12 (+1.02%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.Teladoc Health NYSE:TDOC$7.16 -0.04 (-0.56%) Closing price 04/28/2025 03:59 PM EasternExtended Trading$7.16 0.00 (0.00%) As of 09:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.GeneDx NASDAQ:WGS$112.49 +1.48 (+1.33%) Closing price 04/28/2025 04:00 PM EasternExtended Trading$113.11 +0.62 (+0.55%) As of 09:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 5 Mid-Cap Stocks Insiders Are Buying This Year Alphabet Rebounds After Strong Earnings and Buyback Announcement Occidental’s Hidden Gem: How OxyChem Could Boost Profits T-Mobile US: The Un-Carrier Is an Indisputable Buy on the Dip Kroger: This Must-Own Staples Stock Thrives in Every Market 3M Stock: 4 Compelling Reasons to Buy, 1 Big Reason to Pass Disney: The Compelling Case for Buying Now Before They Scale Up Southwest Airlines CEO Calls Recession, Why Option Traders Jumped Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
